Atlas Trials

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis

Clinical trial NCT03660878 · COMPLETED

Trial details

NCT number
NCT03660878
Sponsor
Aldeyra Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2018-09-08
Primary completion
2019-11-19
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.